Literature DB >> 29479244

Physician perspectives on vaccination and diagnostic testing in children with gastroenteritis: A primary care physician survey.

Arissa J Sperou1, James A Dickinson2, Bonita Lee3, Marie Louie4,5, Xiao-Li Pang6,7, Linda Chui6,7, Otto G Vanderkooi4,8,9, Stephen B Freedman1,10.   

Abstract

OBJECTIVES: Gastroenteritis remains a common paediatric illness. Little is known about physician knowledge of enteric pathogen diagnostic tests. At the time of study conduct, Alberta lacked a publicly funded rotavirus vaccination program and knowledge of primary care physician perspectives was lacking. We sought to ascertain diagnostic testing methods and to understand knowledge and perceptions regarding enteric pathogen vaccination.
METHODS: A 30-item electronic survey was distributed across Alberta's five health care zones. The survey was developed by virology, microbiology, paediatrics, family medicine and public health experts. Participants were members of Alberta's Primary Care Networks, the TARRANT network and The Society of General Pediatricians of Greater Edmonton. Study outcomes included: (1) physician knowledge of available diagnostic tests, (2) perspectives regarding stool sample collection and (3) support for an enteric vaccine program.
RESULTS: Stool culture was reported as the test to identify parasites (47%), viruses (74%) and Clostridium difficile (67%). Although electron microscopy and enzyme immunoassay were used to identify viruses in Alberta during the study period, only 20% and 48% of respondents respectively identified them as tests employed for such purposes. Stool testing was viewed as being inconvenient (62%; 55/89), whereas rectal swabs were thought to have the potential to significantly improve specimen collection rates (82%; 72/88). Seventy-three per cent (66/90) of the respondent physicians support the adoption of future enteric pathogen vaccines.
CONCLUSIONS: Simplification of diagnostic testing and stool sample collection could contribute to improved pathogen identification rates. Implementation of an enteric vaccine into the routine paediatric vaccination schedule is supported by the majority of respondents.

Entities:  

Keywords:  Diagnostic testing; Gastroenteritis; Primary care; Vaccination

Year:  2017        PMID: 29479244      PMCID: PMC5804577          DOI: 10.1093/pch/pxx078

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  15 in total

1.  Estimating the under-reporting rate for infectious gastrointestinal illness in Ontario.

Authors:  Shannon E Majowicz; Victoria L Edge; Aamir Fazil; W Bruce McNab; Kathryn A Doré; Paul N Sockett; James A Flint; Dean Middleton; Scott A McEwen; Jeffery B Wilson
Journal:  Can J Public Health       Date:  2005 May-Jun

2.  Clinicians' opinions on new vaccination programs implementation.

Authors:  E Dubé; V Gilca; C Sauvageau; J A Bettinger; F D Boucher; S McNeil; I Gemmill; F Lavoie; M Ouakki; N Boulianne
Journal:  Vaccine       Date:  2012-05-11       Impact factor: 3.641

3.  Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.

Authors:  Margaret M Cortese; Jacqueline E Tate; Lone Simonsen; Laurel Edelman; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2010-06       Impact factor: 2.129

Review 4.  Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Authors:  Carlo Giaquinto; Geraldine Dominiak-Felden; Pierre Van Damme; Tin Tin Htar Myint; Yvonne A Maldonado; Vana Spoulou; T Christopher Mast; Mary Allen Staat
Journal:  Hum Vaccin       Date:  2011-07-01

5.  Canadian paediatricians' opinions on rotavirus vaccination.

Authors:  E Dubé; V Gilca; C Sauvageau; R Bradet; J A Bettinger; N Boulianne; F D Boucher; S McNeil; I Gemmill; F Lavoie
Journal:  Vaccine       Date:  2011-03-02       Impact factor: 3.641

6.  Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario.

Authors:  P Jacobs; Lg Shane; K Fassbender; El Wang; R Moineddin; El Ford-Jones
Journal:  Can J Infect Dis       Date:  2002-05

7.  Oral ondansetron administration in emergency departments to children with gastroenteritis: an economic analysis.

Authors:  Stephen B Freedman; Michael J Steiner; Kevin J Chan
Journal:  PLoS Med       Date:  2010-10-12       Impact factor: 11.069

8.  Added value of multiplex Luminex Gastrointestinal Pathogen Panel (xTAG® GPP) testing in the diagnosis of infectious gastroenteritis.

Authors:  E Wessels; L G Rusman; M J A W M van Bussel; E C J Claas
Journal:  Clin Microbiol Infect       Date:  2013-10-17       Impact factor: 8.067

9.  Enhanced enteric virus detection in sporadic gastroenteritis using a multi-target real-time PCR panel: a one-year study.

Authors:  Xiaoli L Pang; Jutta K Preiksaitis; Bonita E Lee
Journal:  J Med Virol       Date:  2013-11-14       Impact factor: 2.327

10.  Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis.

Authors:  Li Liu; Shefali Oza; Daniel Hogan; Jamie Perin; Igor Rudan; Joy E Lawn; Simon Cousens; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2014-09-30       Impact factor: 79.321

View more
  2 in total

1.  Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens.

Authors:  Sophonie Jean; Melanie L Yarbrough; Neil W Anderson; C A Burnham
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

2.  A Pilot Study Investigating the Expression Levels of Pluripotency-Associated Genes in Rectal Swab Samples for Colorectal Polyp and Cancer Diagnosis and Prognosis.

Authors:  Ryan Wai-Yan Sin; Dominic Chi-Chung Foo; Deepak Narayanan Iyer; May Sau-Yee Fan; Xue Li; Oswens Siu-Hung Lo; Wai-Lun Law; Lui Ng
Journal:  Stem Cells Int       Date:  2021-07-22       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.